AngioDynamics, Inc.
- Jurisdiction
United States - LEI
549300W3VKC5ZKMO8C28 - ISIN
US03475V1017 (ANGO )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
2
/ 7
Profile
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. Read full profile
Fundamentals
- Net revenue
€248.61M - Gross margin
52.2% - EBIT
-€21.36M - EBIT margin
-8.6% - Net income
-€36.71M - Net margin
-14.8%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Debbie Wasserman Schultz | July 25, 2025 | $1.00K–$15.00K |
| Debbie Wasserman Schultz | July 25, 2025 | $1.00K–$15.00K |
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Sell |
Earnings Calls
Latest earnings call: July 16, 2024 (Q4 2024)